Women’s Health Market Size, Share & Trends Analysis Report By Application (Postmenopausal Osteoporosis, Hormonal Infertility, Endometriosis & Uterine Fibroids, Contraceptives), By Age, By Region, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1 Methodology and Scope
                   1.1 Market Segmentation
                   1.2 Research Methodology
                   1.3 Research Assumptions
                       1.3.1 Estimates and Forecast Timeline
                   1.4 Research Methodology
                   1.5 Information Procurement
                       1.5.1 Purchased Database
                       1.5.2 GVR’s Internal Database
                       1.5.3 Secondary Sources
                       1.5.4 Primary Research
                       1.5.5 Details of Primary Research
                   1.6 Information or Data Analysis
                       1.6.1 Data Analysis Models
                   1.7 Market Formulation & Validation
                   1.8 Model Details
                       1.8.1 Commodity Flow Analysis
                           1.8.1.1 Approach 1: Commodity flow approach
                           1.8.1.2 Approach 2: Country wise market estimation using bottom up approach
                   1.9 Global Market: CAGR Calculation
                   1.10 List of Secondary Sources
                   1.11 List of Primary Sources
                   1.12 Objectives
                       1.12.1 Objective 1:
                       1.12.2 Objective 2:
                   1.13 List of Abbreviations
Chapter 2 Executive Summary
                   2.1 Market Summary
Chapter 3 Women’s Health Market Variables, Trends & Scope
                   3.1 Women’s Health Market Lineage Outlook
                       3.1.1 Parent market outlook
                   3.2 Penetration & Growth Prospect Mapping
                   3.3 Regulatory and Reimbursement Framework
                   3.4 Market Dynamics
                       3.4.1 Market driver analysis
                           3.4.1.1 Rising incidence of target diseases
                           3.4.1.2 Child or early marriages
                           3.4.1.3 Increasing initiatives by government and various organizations
                           3.4.1.4 Rising publicly funded family planning services
                       3.4.2 Market restraint analysis
                           3.4.2.1 Patent expiry of major drugs
                           3.4.2.2 Lawsuits related to products
                           3.4.2.2 Adverse effects associated with use of contraceptive drugs and devices
                   3.5 Women’s Health Market Analysis Tools
                       3.5.1 Porter’s Five Forces Analysis
                       3.5.2 SWOT Analysis; By factor (Political & Legal, Economic and Technological)
                   3.6 Major Deals and Strategic Alliances
                   3.7 Women’s Health Market Analysis Tools
                   3.8 Market size estimates for key products (global level estimates and forecasts)
                       3.8.1. Evista
                           3.8.1.1. Evista Market, 2018 to 2030 (USD Million)
                       3.8.2. Xgeva
                           3.8.2.1. Xgeva Market, 2018 to 2030 (USD Million)
                       3.8.3. Prolia
                           3.8.3.1. Prolia Market, 2018 to 2030 (USD Million)
                       3.8.4. Mirena
                           3.8.4.1. Mirena Market, 2018 to 2030 (USD Million)
                       3.8.5. Zometa
                           3.8.5.1. Zometa Market, 2018 to 2030 (USD Million)
                       3.8.6. Reclast/Aclasta
                           3.8.6.1. Reclast/Aclasta Market, 2018 to 2030 (USD Million)
                       3.8.7. Minastrin 24FE
                           3.8.7.1. Minastrin 24FE Market, 2018 to 2030 (USD Million)
                       3.8.8. NuvaRing
                           3.8.8.1. NuvaRing Market, 2018 to 2030 (USD Million)
                       3.8.9. Forteo
                           3.8.9.1. Forteo Market, 2018 to 2030 (USD Million)
                       3.8.10. Premarin
                           3.8.10.1. Premarin Market, 2018 to 2030 (USD Million)
                       3.8.11. Actonel
                           3.8.11.1. Actonel Market, 2018 to 2030 (USD Million)
                       3.8.12. Ortho-Tri-Cy Lo 28
                           3.8.12.1. Ortho-Tri-Cy Lo 28 Market, 2018 to 2030 (USD Million)
Chapter 4 Application Business Analysis
                   4.1 Women’s Health Market: Application Movement Analysis
                   4.2 Postmenopausal Osteoporosis
                       4.2.1 Postmenopausal Osteoporosis market, 2018 - 2030 (USD Million)
                   4.3 Hormonal Infertility
                       4.3.1 Hormonal infertility market, 2018 - 2030 (USD Million)
                   4.4 Endometriosis and Uterine Fibroids
                       4.4.1 Endometriosis and uterine fibroids market, 2018 - 2030 (USD Million)
                   4.5 Contraceptives
                       4.5.1 Contraceptives market, 2018 - 2030 (USD Million)
                   4.6 Menopause
                       4.6.1 Menopause market, 2018 - 2030 (USD Million)
                   4.7 Polycystic Ovary Syndrome (PCOS)
                       4.7.1 PCOS market, 2018 - 2030 (USD Million)
Chapter 5 Age Segment Analysis
                   5.1 Women’s Health Market: Application Movement Analysis
                   5.2 50 years and above
                       5.2.1 50 years and above market, 2018 - 2030 (USD Million)
                           5.2.1.2 Postmenopausal osteoporosis market, 50 years and above, 2018 - 2030 (USD Million)
                           5.2.1.3 Endometriosis and uterine fibroids market, 50 years and above, 2018 - 2030 (USD Million)
                           5.2.1.4 Menopause market, 50 years and above, 2018 - 2030 (USD Million)
                           5.2.1.5 Others market, 50 years and above, 2018 - 2030 (USD Million)
                   5.3 Others
                       5.3.1 Others market, 2018 - 2030 (USD Million)
Chapter 6 Regional Business Analysis
                   6.1 Women’s Health Market: Regional Outlook
                   6.2 North America
                       6.2.1 North America Women’s Health Market Estimates & Forecasts, 2018 - 2030 (USD Million)
                       6.2.2 U.S.
                           6.2.2.1 Key Country Dynamics
                           6.2.2.2 U.S. Women’s Health Market Estimates & Forecasts, 2018 - 2030 (USD Million)
                           6.2.2.3 Target Disease Prevalence
                           6.2.2.5 Competitive Scenario
                           6.2.2.6 Regulatory Framework
                           6.2.2.7 Reimbursement Scenario
                       6.2.3 Canada
                           6.2.3.1 Key Country Dynamics
                           6.2.3.2 Canada Women’s Health Market Estimates & Forecasts, 2018 - 2030 (USD Million)
                           6.2.3.3 Target Disease Prevalence
                           6.2.3.4 Competitive Scenario
                           6.2.3.5 Regulatory Framework
                           6.2.3.6 Reimbursement Scenario
                   6.3 Europe
                       6.3.1 Europe Women’s Health Market Estimates & Forecasts, 2018 – 2030 (USD Million)
                       6.3.2 U.K.
                           6.3.2.1 Key Country Dynamics
                           6.3.2.2 U.K. Women’s Health Market Estimates & Forecasts, 2018 - 2030 (USD Million)
                           6.3.2.3 Target Disease Prevalence
                           6.3.2.4 Competitive Scenario
                           6.3.2.5 Regulatory Framework
                           6.3.2.6 Reimbursement Scenario
                       6.3.3 Germany
                           6.3.3.1 Key Country Dynamics
                           6.3.3.2 Germany Women’s Health Market Estimates & Forecasts, 2018 - 2030 (USD Million)
                           6.3.3.3 Target Disease Prevalence
                           6.3.3.4 Competitive Scenario
                           6.3.3.5 Regulatory Framework
                           6.3.3.6 Reimbursement Scenario
                       6.3.4 France
                           6.3.4.1 Key Country Dynamics
                           6.3.4.2 France Women’s Health Market Estimates & Forecasts, 2018 - 2030 (USD Million)
                           6.3.4.3 Target Disease Prevalence
                           6.3.4.4 Competitive Scenario
                           6.3.4.5 Regulatory Framework
                           6.3.4.6 Reimbursement Scenario
                       6.3.5 Italy
                           6.3.5.1 Key Country Dynamics
                           6.3.5.2 Italy Women’s Health Market Estimates & Forecasts, 2018 - 2030 (USD Million)
                           6.3.5.3 Target Disease Prevalence
                           6.3.5.4 Competitive Scenario
                           6.3.5.5 Regulatory Framework
                           6.3.5.6 Reimbursement Scenario
                       6.3.6 Spain
                           6.3.6.1 Key Country Dynamics
                           6.3.6.2 Spain Women’s Health Market Estimates & Forecasts, 2018 - 2030 (USD Million)
                           6.3.6.3 Target Disease Prevalence
                           6.3.6.4 Competitive Scenario
                           6.3.6.5 Regulatory Framework
                           6.3.6.6 Reimbursement Scenario
                       6.3.7 Denmark
                           6.3.7.1 Key Country Dynamics
                           6.3.7.2 Denmark Women’s Health Market Estimates & Forecasts, 2018 - 2030 (USD Million)
                           6.3.7.3 Target Disease Prevalence
                           6.3.7.4 Competitive Scenario
                           6.3.7.5 Regulatory Framework
                           6.3.7.6 Reimbursement Scenario
                       6.3.8 Sweden
                           6.3.8.1 Key Country Dynamics
                           6.3.8.2 Sweden Women’s Health Market Estimates & Forecasts, 2018 - 2030 (USD Million)
                           6.3.8.3 Target Disease Prevalence
                           6.3.8.4 Competitive Scenario
                           6.3.8.5 Regulatory Framework
                           6.3.8.6 Reimbursement Scenario
                       6.3.9 Norway
                           6.3.9.1 Key Country Dynamics
                           6.3.9.2 Norway Women’s Health Market Estimates & Forecasts, 2018 - 2030 (USD Million)
                           6.3.9.3 Target Disease Prevalence
                           6.3.9.4 Competitive Scenario
                           6.3.9.5 Regulatory Framework
                           6.3.9.6 Reimbursement Scenario
                   6.4 Asia Pacific
                       6.4.1 Asia Pacific Women’s Health Market Estimates & Forecasts, 2018 – 2030 (USD Million)
                       6.4.2 Japan
                           6.4.2.1 Key Country Dynamics
                           6.4.2.2 Japan Women’s Health Market Estimates & Forecasts, 2018 - 2030 (USD Million)
                           6.4.2.3 Target Disease Prevalence
                           6.4.2.4 Competitive Scenario
                           6.4.2.5 Regulatory Framework
                           6.4.2.6 Reimbursement Scenario
                       6.4.3 China
                           6.4.3.1 Key Country Dynamics
                           6.4.3.2 China Women’s Health Market Estimates & Forecasts, 2018 - 2030 (USD Million)
                           6.4.3.3 Target Disease Prevalence
                           6.4.3.4 Competitive Scenario
                           6.4.3.5 Regulatory Framework
                           6.4.3.6 Reimbursement Scenario
                       6.4.4 India
                           6.4.4.1 Key Country Dynamics
                           6.4.4.2 India Women’s Health Market Estimates & Forecasts, 2018 - 2030 (USD Million)
                           6.4.4.3 Target Disease Prevalence
                           6.4.4.4 Competitive Scenario
                           6.4.4.5 Regulatory Framework
                           6.4.4.6 Reimbursement Scenario
                       6.4.5 Australia
                           6.4.5.1 Key Country Dynamics
                           6.4.5.2 Australia Women’s Health Market Estimates & Forecasts, 2018 - 2030 (USD Million)
                           6.4.5.3 Target Disease Prevalence
                           6.4.5.4 Competitive Scenario
                           6.4.5.5 Regulatory Framework
                           6.4.5.6 Reimbursement Scenario
                       6.4.6 South Korea
                           6.4.6.1 Key Country Dynamics
                           6.4.6.2 South Korea Women’s Health Market Estimates & Forecasts, 2018 - 2030 (USD Million)
                           6.4.6.3 Target Disease Prevalence
                           6.4.6.4 Competitive Scenario
                           6.4.6.5 Regulatory Framework
                           6.4.6.6 Reimbursement Scenario
                       6.4.7 Thailand
                           6.4.7.1 Key Country Dynamics
                           6.4.7.2 Thailand Women’s Health Market Estimates & Forecasts, 2018 - 2030 (USD Million)
                           6.4.7.3 Target Disease Prevalence
                           6.4.7.4 Competitive Scenario
                           6.4.7.5 Regulatory Framework
                           6.4.7.6 Reimbursement Scenario
                   6.5 Latin America
                       6.5.1 Latin America Women’s Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                       6.5.2 Brazil
                           6.5.2.1 Key Country Dynamics
                           6.5.2.2 Brazil Women’s Health Market Estimates & Forecasts, 2018 - 2030 (USD Million)
                           6.5.2.3 Target Disease Prevalence
                           6.5.2.4 Competitive Scenario
                           6.5.2.5 Regulatory Framework
                           6.5.2.6 Reimbursement Scenario
                       6.5.3 Mexico
                           6.5.3.1 Key Country Dynamics
                           6.5.3.2 Mexico Women’s Health Market Estimates & Forecasts, 2018 - 2030 (USD Million)
                           6.5.3.3 Target Disease Prevalence
                           6.5.3.4 Competitive Scenario
                           6.5.3.5 Regulatory Framework
                           6.5.3.6 Reimbursement Scenario
                       6.5.4 Argentina
                           6.5.4.1 Key Country Dynamics
                           6.5.4.2 Argentina Women’s Health Market Estimates & Forecasts, 2018 - 2030 (USD Million)
                           6.5.4.3 Target Disease Prevalence
                           6.5.4.4 Competitive Scenario
                           6.5.4.5 Regulatory Framework
                           6.5.4.6 Reimbursement Scenario
                   6.6 Middle East and Africa
                       6.6.1 Middle East and Africa Women’s Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                           6.6.1.1 Target Disease Prevalence
                           6.6.1.2 Competitive Scenario
                           6.6.1.3 Regulatory Framework
                           6.6.1.4 Reimbursement Scenario
                       6.6.2 South Africa
                           6.6.2.1 Key Country Dynamics
                           6.6.2.2 South Africa Women’s Health Market Estimates & Forecasts, 2018 - 2030 (USD Million)
                           6.6.2.3 Target Disease Prevalence
                           6.6.2.4 Competitive Scenario
                           6.6.2.5 Regulatory Framework
                           6.6.2.6 Reimbursement Scenario
                       6.6.3 Saudi Arabia
                           6.6.3.1 Key Country Dynamics
                           6.6.3.2 Saudi Arabia Women’s Health Market Estimates & Forecasts, 2018 - 2030 (USD Million)
                           6.6.3.3 Target Disease Prevalence
                           6.6.3.4 Competitive Scenario
                           6.6.3.5 Regulatory Framework
                           6.6.3.6 Reimbursement Scenario
                       6.6.4 UAE
                           6.6.4.1 Key Country Dynamics
                           6.6.4.2 UAE Women’s Health Market Estimates & Forecasts, 2018 - 2030 (USD Million)
                           6.6.4.3 Target Disease Prevalence
                           6.6.4.4 Competitive Scenario
                           6.6.4.5 Regulatory Framework
                           6.6.4.6 Reimbursement Scenario
                       6.6.5 Kuwait
                           6.6.5.1 Key Country Dynamics
                           6.6.5.2 Kuwait Women’s Health Market Estimates & Forecasts, 2018 - 2030 (USD Million)
                           6.6.5.3 Target Disease Prevalence
                           6.6.5.4 Competitive Scenario
                           6.6.5.5 Regulatory Framework
                           6.6.5.6 Reimbursement Scenario
Chapter 7 Competitive Landscape
                   7.1 Company Categorization
                   7.2 Strategy Mapping
                       7.2.1 New Product Launch
                       7.2.2 Partnerships
                       7.2.3 Acquisition
                       7.2.4 Collaboration
                       7.2.5 Funding
                   7.3 Key Company Market Share Analysis, 2022
                   7.4 Company Profiles
                       7.4.1 AbbVie, Inc.
                           7.4.1.1 Company Overview
                           7.4.1.2 Financial Performance
                           7.4.1.3 Product Benchmarking
                           7.4.1.4 Strategic Initiatives
                       7.4.2 Bayer AG
                           7.4.2.1 Company Overview
                           7.4.2.2 Financial Performance
                           7.4.2.3 Product Benchmarking
                           7.4.2.4 Strategic Initiatives
                       7.4.3 Merck & Co., Inc.
                           7.4.3.1 Company Overview
                           7.4.3.2 Financial Performance
                           7.4.3.3 Product Benchmarking
                           7.4.3.4 Strategic Initiatives
                       7.4.4 Pfizer, Inc.
                           7.4.4.1 Company Overview
                           7.4.4.2 Financial Performance
                           7.4.4.3 Product Benchmarking
                           7.4.4.4 Strategic Initiatives
                       7.4.5 Teva Pharmaceutical Industries Ltd.
                           7.4.5.1 Company Overview
                           7.4.5.2 Financial Performance
                           7.4.5.3 Product Benchmarking
                           7.4.5.4 Strategic Initiatives
                       7.4.6 Agile Therapeutics
                           7.4.6.1 Company Overview
                           7.4.6.2 Financial Performance
                           7.4.6.3 Product Benchmarking
                           7.4.6.4 Strategic Initiatives
                       7.4.7 Amgen, Inc.
                           7.4.7.1 Company Overview
                           7.4.7.2 Financial Performance
                           7.4.7.3 Product Benchmarking
                           7.4.7.4 Strategic Initiatives
                       7.4.8 Apothecus Pharmaceutical Corp.
                           7.4.8.1 Company Overview
                           7.4.8.2 Financial Performance
                           7.4.8.3 Product Benchmarking
                           7.4.8.4 Strategic Initiatives
                       7.4.9 Blairex Laboratories, Inc.)
                           7.4.9.1 Company Overview
                           7.4.9.2 Financial Performance
                           7.4.9.3 Product Benchmarking
                           7.4.9.4 Strategic Initiatives
                       7.4.10 Ferring B.V.
                           7.4.10.1 Company Overview
                           7.4.10.2 Financial Performance
                           7.4.10.3 Product Benchmarking
                           7.4.10.4 Strategic Initiatives

List of Tables

TABLE 1 List of secondary sources
TABLE 2 List of Abbreviations
TABLE 3 North America Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 4 North America Women’s Health market estimates and forecasts, by age, 2018 - 2030
TABLE 5 U.S. Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 6 U.S. Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
TABLE 7 Canada Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 8 Canada Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
TABLE 9 Europe Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 10 Europe Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
TABLE 11 UK Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 12 UK Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
TABLE 13 Germany Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 14 Germany Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
TABLE 15 France Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 16 France Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
TABLE 17 Italy Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 18 Italy Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
TABLE 19 Spain Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 20 Spain Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
TABLE 21 Denmark Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 22 Denmark Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
TABLE 23 Sweden Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 24 Sweden Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
TABLE 25 Norway Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 26 Norway Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
TABLE 27 Asia Pacific Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 28 Asia Pacific Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
TABLE 29 Japan Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 30 Japan Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
TABLE 31 China Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 32 China Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
TABLE 33 India Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 34 India Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
TABLE 35 Australia Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 36 Australia Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
TABLE 37 South Korea Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 38 South Korea Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
TABLE 39 Thailand Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 40 Thailand Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
TABLE 41 Latin America Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 42 Latin America Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
TABLE 43 Brazil Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 44 Brazil Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
TABLE 45 Mexico Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 46 Mexico Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
TABLE 47 Argentina Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 48 Argentina Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
TABLE 49 MEA Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 50 MEA Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
TABLE 51 South Africa Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 52 South Africa Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
TABLE 53 Saudi Arabia Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 54 Saudi Arabia Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
TABLE 55 UAE Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 56 UAE Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
TABLE 57 Kuwait Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 58 Kuwait Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)

List of Figures

FIG. 1 Women’s health market segmentation
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value chain-based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market formulation & validation
FIG. 9 Women’s health market snapshot
FIG. 10 Market trends & outlook
FIG. 11 Penetration & growth prospect mapping
FIG. 12 Consumer Behavior Analysis
FIG. 13 Market driver relevance analysis (Current & future impact)
FIG. 14 Market restraint relevance analysis (Current & future impact)
FIG. 15 Porter’s five forces analysis
FIG. 16 Evista market, 2018 - 2030 (USD Million)
FIG. 17 Xgeva market, 2018 - 2030 (USD Million)
FIG. 18 Prolia market, 2018 - 2030 (USD Million)
FIG. 19 Mirena market, 2018 - 2030 (USD Million)
FIG. 20 Zometa market, 2018 - 2030 (USD Million)
FIG. 21 Reclast/Aclasta market, 2018 - 2030 (USD Million)
FIG. 22 Minastrin 24FE market, 2018 - 2030 (USD Million)
FIG. 23 NuvaRing market, 2018 - 2030 (USD Million)
FIG. 24 Forteo market, 2018 - 2030 (USD Million)
FIG. 25 Premarin market, 2018 - 2030 (USD Million)
FIG. 26 Actonel market, 2018 - 2030 (USD Million)
FIG. 27 Ortho-Tri-Cy Lo 28 market, 2018 - 2030 (USD Million)
FIG. 28 Women’s health application market share analysis, 2022 & 2030
FIG. 29 Women’s health application market: Segment dashboard
FIG. 30 Postmenopausal osteoporosis market, 2018 - 2030 (USD Million)
FIG. 31 Hormonal infertility market, 2018 - 2030 (USD Million)
FIG. 32 Endometriosis & Uterine Fibroids market, 2018 - 2030 (USD Million)
FIG. 33 Contraceptives market, 2018 - 2030 (USD Million)
FIG. 34 Menopause market, 2018 - 2030 (USD Million)
FIG. 35 PCOS market, 2018 - 2030 (USD Million)
FIG. 36 Women’s health age market share analysis, 2022 & 2030
FIG. 37 Women’s health age market: Segment dashboard
FIG. 38 50 years and above market, 2018 - 2030 (USD Million)
FIG. 39 Postmenopausal Osteoporosis market, 50 years and above, 2018 - 2030 (USD Million)
FIG. 40 Endometriosis market, 50 years and above, 2018 - 2030 (USD Million)
FIG. 41 Menopause market, 50 years and above, 2018 - 2030 (USD Million)
FIG. 42 Others market, 50 years and above, 2018 - 2030 (USD Million)
FIG. 43 Others market, 2018 - 2030 (USD Million)
FIG. 44 Women’s health market: Regional outlook and key takeaways
FIG. 45 Women’s health market: Regional movement analysis
FIG. 46 North America SWOT analysis
FIG. 47 North America market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 48 U.S. key country dynamics
FIG. 49 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 50 Canada key country dynamics
FIG. 51 Canada market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 52 Europe SWOT analysis
FIG. 53 Europe market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 54 UK key country dynamics
FIG. 55 UK market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 56 Germany key country dynamics
FIG. 57 Germany market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 58 Italy key country dynamics
FIG. 59 Italy market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 60 Spain key country dynamics
FIG. 61 Spain market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 62 France key country dynamics
FIG. 63 France market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 64 Denmark key country dynamics
FIG. 65 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 66 Sweden key country dynamics
FIG. 67 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 68 Norway key country dynamics
FIG. 69 Norway market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 70 Asia Pacific SWOT analysis
FIG. 71 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 72 Japan key country dynamics
FIG. 73 Japan market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 74 China key country dynamics
FIG. 75 China market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 76 India key country dynamics
FIG. 77 India market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 78 Australia key country dynamics
FIG. 79 Australia market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 80 South Korea key country dynamics
FIG. 81 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 82 Thailand key country dynamics
FIG. 83 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 84 Latin America SWOT analysis
FIG. 85 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 86 Brazil key country dynamics
FIG. 87 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 88 Mexico key country dynamics
FIG. 89 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 90 Argentina key country dynamics
FIG. 91 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 92 Middle East & Africa SWOT analysis
FIG. 93 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 94 South Africa key country dynamics
FIG. 95 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 96 Saudi Arabia key country dynamics
FIG. 97 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 98 UAE key country dynamics
FIG. 99 UAE market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 100 Kuwait key country dynamics
FIG. 101 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)